Attenuation of Candida albicans virulence with focus on disruption of its vacuole functions

Ingar Olsen1

  • 1Department of Oral Biology, Faculty of Dentistry, University of Oslo, Oslo, Norway.

Insights

Targeting the yeast vacuole could reduce Candida albicans virulence. Inhibiting vacuolar functions, like proton-translocating ATPase (V-ATPase), offers a promising strategy against this difficult-to-treat fungal pathogen.

Area of Science:

  • Medical Microbiology
  • Mycology
  • Infectious Diseases

Background:

  • Candida albicans is an opportunistic fungal pathogen responsible for a range of infections, from superficial to life-threatening systemic diseases.
  • Current antifungal treatments face challenges due to emerging resistance and difficulties in complete eradication, often necessitating lifelong management.
  • The yeast vacuole plays critical roles in cellular homeostasis, stress response, and virulence factor regulation in C. albicans.

Purpose of the Study:

  • To review the potential of the yeast vacuole as a therapeutic target for attenuating Candida albicans virulence.
  • To explore novel strategies for managing C. albicans infections by targeting vacuolar functions.

Main Methods:

  • Systematic literature search conducted in PubMed and leading microbiology journals.
  • Inclusion criteria were predetermined to ensure a focused review of relevant studies.
  • Analysis of research on inhibiting vacuolar proton-translocating ATPase (V-ATPase) and its impact on C. albicans.

Main Results:

  • Inhibiting vacuolar proton-translocating ATPase (V-ATPase) function and yeast vacuole acidification can reduce C. albicans virulence.
  • Synergistic effects observed with combined antifungal and non-antifungal agents targeting vacuolar functions.
  • Inhibition of filament production, regulated by the vacuole, also shows potential for virulence attenuation.

Conclusions:

  • The yeast vacuole is a viable target for impairing Candida albicans virulence during host colonization and invasion.
  • While some interventions are theoretical, targeting vacuolar functions offers a promising alternative to complete eradication, especially for recalcitrant infections.
  • Further research into redefining drug indications and developing novel vacuole-targeting strategies is warranted.